Wuhan YZY Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: 2496 only recently listed within the past 12 months

Top 18 shareholders own 87.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.4%	CSPC Pharmaceutical Group Limited	51,241,785	HK$381.8m	0%	no data
10.5%	Qian Yuan	20,399,933	HK$152.0m	0%	no data
8.66%	Wuhan YZY Biopharma Co., Ltd, ESOP	16,792,707	HK$125.1m	0%	no data
5.36%	Tongde Qianyuan (Beijing) Investment Management Co., Ltd.	10,396,143	HK$77.5m	0%	no data
5.26%	Hongfeng Zhou	10,199,921	HK$76.0m	0%	no data
4.27%	Wuhan Optics Valley Industrial Investment Co., Ltd.	8,286,000	HK$61.7m	0%	no data
4.08%	Long Star Growth Group Limited	7,916,510	HK$59.0m	0%	no data
3.94%	Hainan Boyou Enterprise Management Consulting Center (Limited Partnership)	7,628,713	HK$56.8m	0%	no data
3.71%	Ningbo Meishan Bonded Port Area Guangrui Hongxiang Equity Investment Partnership (Limited Partnershi	7,196,835	HK$53.6m	0%	no data
3.61%	Wuhan Optics Valley New Technology Industry Investment Co., Ltd.	7,000,000	HK$52.1m	0%	no data
3.54%	Pengfei Zhou	6,869,744	HK$51.2m	0%	no data
3%	Nanjing Caizhi No. 2 Enterprise Management Partnership	5,810,205	HK$43.3m	0%	no data
1.78%	Nanning Yaoyou Business Consulting Partnership Enterprise (Limited Partnership)	3,447,526	HK$25.7m	0%	no data
1.44%	Wuhan Optics Valley Growth Venture Capital Management Co., Ltd.	2,800,000	HK$20.9m	0%	no data
0.83%	Gongqingcheng Huiyou Xingyao Phase Ii Equity Investment Partnership (Limited Partnership)	1,611,513	HK$12.0m	0%	no data
0.69%	Chengdu Puhua Kaizhi Biotechnology Co., Ltd.	1,342,600	HK$10.0m	0%	no data
0.19%	Hongwei Guo	370,087	HK$2.8m	0%	no data
0.077%	Chen Linan	149,278	HK$1.1m	0%	no data